Kawin Technology Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 584

Employees

  • Stock Symbol
  • 688687

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $3.47
  • (As of Thursday Closing)

Kawin Technology General Information

Description

Beijing Kawin Technology Share-Holding Co Ltd is a biotechnology company. It offers healthcare solutions for liver disease. The company's products include Pirfenidone Tablets, Peginterferon Alfacon-2 Injection, and Compound glycyrrhizin capsules.

Contact Information

Website
www.kawin.com.cn
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • No. 6 Rongjing Street East
  • Beijing Economic and Technological Development Zone
  • Beijing, 100176
  • China
+86 010
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
SHG
Vertical(s)
Life Sciences
Corporate Office
  • No. 6 Rongjing Street East
  • Beijing Economic and Technological Development Zone
  • Beijing, 100176
  • China
+86 010

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kawin Technology Stock Performance

As of 27-Mar-2025, Kawin Technology’s stock price is $3.47. Its current market cap is $593M with 171M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.47 $3.29 $2.68 - $4.81 $593M 171M 3.11M $0.11

Kawin Technology Financials Summary

As of 30-Sep-2024, Kawin Technology has a trailing 12-month revenue of $198M.

In Thousands,
USD 		TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 561,689 662,052 390,951 540,313
Revenue 197,862 199,580 172,242 177,225
EBITDA 21,594 23,831 17,576 21,412
Net Income 18,715 16,470 12,385 16,616
Total Assets 375,981 345,373 320,282 341,654
Total Debt 39,028 7,748 2,264 536
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kawin Technology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kawin Technology‘s full profile, request access.

Request a free trial

Kawin Technology Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Kawin Technology‘s full profile, request access.

Request a free trial

Kawin Technology Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Kawin Technology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4180456-A1 Antibody binding to hepatitis b virus surface antigen and application of antibody Pending 09-Jul-2020
US-20230265168-A1 Antibody binding to hepatitis b virus surface antigen and application of antibody Pending 09-Jul-2020
EP-4180456-A4 Antibody binding to hepatitis b virus surface antigen and application of antibody Pending 09-Jul-2020 C07K16/082

Kawin Technology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kawin Technology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kawin Technology‘s full profile, request access.

Request a free trial

Kawin Technology Investments (2)

Kawin Technology’s most recent deal was a Early Stage VC with Sciwind Biosciences for . The deal was made on 11-Jan-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sciwind Biosciences 11-Jan-2019 Early Stage VC Biotechnology
Ginkgo 03-Aug-2015 Corporate Drug Discovery
To view Kawin Technology’s complete investments history, request access »

Kawin Technology FAQs

  • When was Kawin Technology founded?

    Kawin Technology was founded in 2008.

  • Where is Kawin Technology headquartered?

    Kawin Technology is headquartered in Beijing, China.

  • What is the size of Kawin Technology?

    Kawin Technology has 584 total employees.

  • What industry is Kawin Technology in?

    Kawin Technology’s primary industry is Pharmaceuticals.

  • Is Kawin Technology a private or public company?

    Kawin Technology is a Public company.

  • What is Kawin Technology’s stock symbol?

    The ticker symbol for Kawin Technology is 688687.

  • What is the current stock price of Kawin Technology?

    As of 27-Mar-2025 the stock price of Kawin Technology is $3.47.

  • What is the current market cap of Kawin Technology?

    The current market capitalization of Kawin Technology is $593M.

  • What is Kawin Technology’s current revenue?

    The trailing twelve month revenue for Kawin Technology is $198M.

  • What is Kawin Technology’s annual earnings per share (EPS)?

    Kawin Technology’s EPS for 12 months was $0.11.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »